General Information of Drug (ID: DMXHAVK)

Drug Name
MCTP-39
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Investigative [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
D09VQW

References

1 NSD2 is a conserved driver of metastatic prostate cancer progression.Nat Commun. 2018 Dec 5;9(1):5201.